AI assistant
Sending…
Celularity Inc — Director's Dealing 2023
Feb 15, 2023
34506_dirs_2023-02-14_2b49a196-dfcb-4e99-a335-bc2e90272e21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2023-02-10
Reporting Person: Diamandis Peter (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-10 | Class A Common Stock | M | 1071000 | $0.28 | Acquired | 1107145 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-10 | Stock Option (Right to Buy) | $0.28 | M | 1071000 | Disposed | 2027-06-02 | Class A Common Stock (1071000) | Direct |
Footnotes
F1: Includes 36,145 shares underlying restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs vest and become exercisable on the earlier of the one-year anniversary of the date of grant, July 13, 2022, and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date.
F2: This option is fully vested and exercisable.
More from Celularity Inc
Regulatory Filings
2026
May 28
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15
Director's Dealing
2026
Jan 15